103 related articles for article (PubMed ID: 7062289)
1. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
Saini RK; Antonaccio MJ
J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
[No Abstract] [Full Text] [Related]
2. Tiapamil--a new calcium antagonist.
Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
[TBL] [Abstract][Full Text] [Related]
3. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
Eigenmann R; Gerold M; Hefti F; Jovanovic D; Haeusler G
Arzneimittelforschung; 1981; 31(9):1401-10. PubMed ID: 7197946
[No Abstract] [Full Text] [Related]
4. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic actions of a long acting verapamil analogue, anipamil, in pigs.
Ries C; Harvie CJ; Walker MJ; Pugsley MK
Proc West Pharmacol Soc; 1993; 36():95-8. PubMed ID: 8378404
[No Abstract] [Full Text] [Related]
6. Effect of tiapamil on canine myocardial infarct size.
Kordenat K; Leasure J
Am Heart J; 1986 Mar; 111(3):502-12. PubMed ID: 3953359
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
Shargorodsky BM; Braun S; Belhassen B; Laniado S
Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
[TBL] [Abstract][Full Text] [Related]
8. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations].
Storozhuk BG; Stoliarchuk AA
Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988
[TBL] [Abstract][Full Text] [Related]
9. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
Diederich KW; Boyksen D
Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
[No Abstract] [Full Text] [Related]
10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
Gerold M; Eigenmann R; Haeusler G
J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
[TBL] [Abstract][Full Text] [Related]
12. [Antifibrillatory and cardiovascular effects of VULM 456, a quaternary salt of exaprolol, on anesthetized dogs].
Jezek L; Kochman J; Mahrla Z; Gasparík J; Spevák R
Cesk Fysiol; 1988; 37(6):521-4. PubMed ID: 3242854
[No Abstract] [Full Text] [Related]
13. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
[TBL] [Abstract][Full Text] [Related]
14. Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon.
Rogers GG; Rosendorff C; Shimell CJ; Coull A
Cardiology; 1982; 69 Suppl():58-67. PubMed ID: 7151084
[TBL] [Abstract][Full Text] [Related]
15. Overview on the pharmacological and toxicological characterization of the calcium antagonist tiapamil.
Haeusler G; Eigenmann R; Gerold M; Hefti F; Jovanovic D; Blaber L; Nakamura K; Thorens S
Cardiology; 1982; 69 Suppl():31-57. PubMed ID: 7151083
[No Abstract] [Full Text] [Related]
16. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
Lessem J
Cardiology; 1982; 69 Suppl():199-208. PubMed ID: 7151080
[TBL] [Abstract][Full Text] [Related]
17. Protection by the calcium antagonist tiapamil, against cardiac lymphatic enzyme leakage and arrhythmias in canine hearts during reperfusion.
Matsuura A; Ishihara T; Nakamura K; Himori N; Nakamura K
J Cardiovasc Pharmacol; 1986; 8(1):90-8. PubMed ID: 2419700
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and hemodynamic responses to adenosine triphosphate during infusion of epinephrine in dogs anesthetized with halothane.
Sohn YZ; Hong JC; Katz RL
Anesth Analg; 1982 May; 61(5):423-9. PubMed ID: 7199866
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic activity of Ro-5-5340 in dogs with acute myocardial infarction.
Yeager HC; Scriabine A; Bellet S
Arch Int Pharmacodyn Ther; 1968 Oct; 175(2):304-8. PubMed ID: 5702949
[No Abstract] [Full Text] [Related]
20. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
Raeder EA; Verrier RL; Lown B
Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
